A specialty pharmaceutical business focused on developing and commercializing pain and central nervous system treatments, built around its proprietary extended‑release drug delivery technology. The company has marketed products for chronic pain and migraine and has expanded its portfolio through lic...
2 members of Congress have disclosed 13 trades in Depomed, Inc. (DEPO), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 9 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-03-24 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-06-21 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-05-24 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-05-04 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-02-27 | JAMES B. RENACCI | sell | $1K – $15K |
| 2015-02-27 | JAMES B. RENACCI | sell | $1K – $15K |
| 2012-11-07 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2012-11-07 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2012-10-07 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2012-10-07 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2012-01-07 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2011-03-05 | MICHAEL T. MCCAUL | buy | $15K – $50K |
| 2011-03-05 | MICHAEL T. MCCAUL | sell | $1K – $15K |